DOI-induced deficits in prepulse inhibition in Wistar rats are reversed by mGlu2/3 receptor stimulation

Pharmacology Biochemistry and Behavior

Volumn 102, Issue 1, 2012, Pages 6-12

  Wischhof, Lena ^a   Aho, Helena E A ^a   Koch, Michael ^a  

^a UNIVERSITY OF BREMEN   (Germany)

Author keywords

5 HT2A receptors; Glutamate; LY379268; Schizophrenia; Sensorimotor gating; Serotonin

Indexed keywords

4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; SEROTONIN 2A RECEPTOR;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; LISTER HOODED RAT; NEUROLOGIC DISEASE; NONHUMAN; PREPULSE INHIBITION; PREPULSE INHIBITION DEFICIT; PRIORITY JOURNAL; RAT; RAT STRAIN; STARTLE REFLEX; WISTAR RAT;

ACOUSTIC STIMULATION; AMINO ACIDS; AMPHETAMINES; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; INHIBITION (PSYCHOLOGY); RANDOM ALLOCATION; RATS; RATS, INBRED STRAINS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; SENSORY GATING; SEROTONIN RECEPTOR AGONISTS; SPECIES SPECIFICITY; STARTLE REACTION;

RATTUS; RATTUS NORVEGICUS;

EID: 84859514079     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.03.011     Document Type: Article

References (78)

1. G.K. Aghajanian, and G.J. Marek Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells Neuropharmacology 36 1997 589 599 (Pubitemid 27272104)
2. N. Amitai, and A. Markou Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats Eur J Pharmacol 639 2010 67 80
3. N.M. Appel, W.M. Mitchell, R.K. Garlick, R.A. Glennon, M. Teitler, and E.B. Desouza Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[I- 125]Iodophenyl)-2-aminopropane ([I-125]Doi) binding to 5-Ht2 and 5-Ht1C receptors in rat-brain J Pharmacol Exp Ther 255 1990 843 857
4. V.P. Bakshi, M. Tricklebank, H.C. Neijt, V. Lehmann-Masten, and M.A. Geyer Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-d-aspartate receptor antagonists in rats J Pharmacol Exp Ther 288 1999 643 652 (Pubitemid 29119676)
5. T. Bast, W. Zhang, J. Feldon, and I.M. White Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats Pharmacol Biochem Behav 67 2000 647 658 (Pubitemid 32103577)
6. D.L. Braff, M.A. Geyer, and N.R. Swerdlow Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies Psychopharmacology (Berl) 156 2001 234 258 (Pubitemid 32705488)
7. J. Cartmell, J.A. Monn, and D.D. Schoepp Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine Psychopharmacology (Berl) 148 2000 423 429 (Pubitemid 30169761)
8. F.X. Castellanos, E.J. Fine, D. Kaysen, W.L. Marsh, J.L. Rapoport, and M. Hallett Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results Biol Psychiatry 39 1996 33 41 (Pubitemid 26022681)
9. P.A. Csomor, B.K. Yee, F.X. Vollenweider, J. Feldon, T. Nicolet, and B.B. Quednow On the influence of baseline startle reactivity on the indexation of prepulse inhibition Behav Neurosci 122 2008 885 900
10. W.D. Essman, R.R. Luedtke, P. McGonigle, and I. Lucky Variations in the behavioral responses to apomorphine in different strains of rats Behav Pharmacol 6 1995 4 15
11. R. Galici, N.G. Echemendia, A.L. Rodriguez, and P.J. Conn A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity J Pharmacol Exp Ther 315 2005 1181 1187 (Pubitemid 41635406)
12. F.R. George, L.J. Porrino, M.C. Ritz, and S.R. Goldberg Inbred rat strain comparisons indicate different sites of action for cocaine and amphetamine locomotor stimulant effects Psychopharmacology (Berl) 104 1991 457 462
13. J.C. Gewirtz, and G.J. Marek Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors Neuropsychopharmacology 23 2000 569 576
14. M.A. Geyer, L.R. Petersen, G.J. Rose, D.D. Horwitt, R.K. Light, and L.M. Adams The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle J Pharmacol Exp Ther 207 1978 837 847 (Pubitemid 9126605)
15. M.A. Geyer, K. Krebs-Thomson, D.L. Braff, and N.R. Swerdlow Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review Psychopharmacology (Berl) 156 2001 117 154 (Pubitemid 32702206)
16. J. Gonzalez-Maeso, R.L. Ang, T. Yuen, P. Chan, N.V. Weisstaub, and J.F. Lopez-Gimenez Identification of a serotonin/glutamate receptor complex implicated in psychosis Nature 452 2008 93 97 (Pubitemid 351355090)
17. J. González-Maeso, R.L. Ang, T. Yuen, P. Chan, N.V. Weisstaub, and J.F. Lopez-Gimenez Identification of a serotonin/glutamate receptor complex implicated in psychosis Nature 452 2008 93 97 (Pubitemid 351355090)
18. E. Gouzoulis-Mayfrank, K. Heekeren, B. Thelen, H. Lindenblatt, K.A. Kovar, and H. Sass Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans Behav Pharmacol 9 1998 561 566 (Pubitemid 28552549)
19. C. Grillon, R. Sinha, and S.S. O'Malley Effects of ethanol on the acoustic startle reflex in humans Psychopharmacology (Berl) 114 1994 167 171 (Pubitemid 24150535)
20. A.L. Halberstadt, d.H.I. van, M.A. Ruderman, V.B. Risbrough, J.A. Gingrich, and M.A. Geyer 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice Neuropsychopharmacology 34 2009 1958 1967
21. K. Heekeren, A. Neukirch, J. Daumann, M. Stoll, M. Obradovic, and K.A. Kovar Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N, N-dimethyltryptamine (DMT) models of psychosis J Psychopharmacol 21 2007 312 320 (Pubitemid 46934051)
22. S.A. Henry, V. Lehmann-Masten, F. Gasparini, M.A. Geyer, and A. Markou The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity Neuropharmacology 43 2002 1199 1209 (Pubitemid 36084431)
23. H. Hikichi, M. Nishino, M. Fukushima, A. Satow, S. Maehara, and H. Kawamoto Pharmacological effects of metabotropic glutamate receptor ligands on prepulse inhibition in DBA/2J mice Eur J Pharmacol 639 2010 99 105
24. K. Hoenig, A. Hochrein, B.B. Quednow, W. Maier, and M. Wagner Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder Biol Psychiatry 57 2005 1153 1158 (Pubitemid 40615777)
25. R.L. Jakab, and P.S. Goldman-Rakic 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites Proc Natl Acad Sci U S A 95 1998 735 740
26. C. Johansson, D.M. Jackson, J.H. Zhang, and L. Svensson Prepulse inhibition of acoustic startle, a measure of sensorimotor gating - effects of antipsychotics and other agents in rats Pharmacol Biochem Behav 52 1995 649 654
27. C.K. Jones, and H.E. Shannon Effects of scopolamine in comparison with apomorphine and phencyclidine on prepulse inhibition in rats Eur J Pharmacol 391 2000 105 112 (Pubitemid 30138086)
28. J.H. Kehne, R.A. Padich, T.C. McCloskey, V.L. Taylor, and C.J. Schmidt 5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats Psychopharmacology (Berl) 124 1996 95 106 (Pubitemid 26112777)
29. G.G. Kinney, L.O. Wilkinson, K.L. Saywell, and M.D. Tricklebank Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity J Neurosci 19 1999 5644 5653 (Pubitemid 29300226)
30. B.J. Kinon, L. Zhang, B.A. Millen, O.O. Osuntokun, J.E. Williams, and S. Kollack-Walker A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia J Clin Psychopharmacol 31 2011 349 355
31. A. Klodzinska, M. Bijak, K. Tokarski, and A. Pilc Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice Pharmacol Biochem Behav 73 2002 327 332 (Pubitemid 34765571)
32. A.R. Knight, A. Misra, K. Quirk, K. Benwell, D. Revell, and G. Kennett Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors Naunyn Schmiedebergs Arch Pharmacol 370 2004 114 123 (Pubitemid 39222863)
33. M. Koch The neurobiology of startle Prog Neurobiol 59 1999 107 128 (Pubitemid 29425879)
34. M. Koch, and H.U. Schnitzler The acoustic startle response in rats - circuits mediating evocation, inhibition and potentiation Behav Brain Res 89 1997 35 49 (Pubitemid 28062697)
35. T. Koskinen, S. Ruotsalainen, T. Puumala, R. Lappalainen, E. Koivisto, and P.T. Mannisto Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task Neuropharmacology 39 2000 471 481 (Pubitemid 30052936)
36. G.J. Marek, R.A. Wright, D.D. Schoepp, J.A. Monn, and G.K. Aghajanian Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex J Pharmacol Exp Ther 292 2000 76 87 (Pubitemid 30026356)
37. G.J. Marek, R.A. Wright, J.C. Gewirtz, and D.D. Schoepp A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex Neuroscience 105 2001 379 392 (Pubitemid 32728122)
38. J.R. Martin, M. Bos, F. Jenck, J. Moreau, V. Mutel, and A.J. Sleight 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential J Pharmacol Exp Ther 286 1998 913 924 (Pubitemid 29003485)
39. Z.A. Martinez, N.D. Halim, J.L. Oostwegel, M.A. Geyer, and N.R. Swerdlow Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats Pharmacol Biochem Behav 65 2000 449 457 (Pubitemid 30100676)
40. U. Meincke, G.A. Light, M.A. Geyer, D.L. Braff, and E. Gouzoulis-Mayfrank Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia Psychiatry Res 126 2004 51 61 (Pubitemid 38479795)
41. B. Moghaddam, and B.W. Adams Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats Science 281 1998 1349 1352 (Pubitemid 28406826)
42. J.A. Monn, M.J. Valli, S.M. Massey, R.A. Wright, C.R. Salhoff, and B.G. Johnson Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties J Med Chem 40 1997 528 537 (Pubitemid 27080033)
43. J.L. Moreno, T. Holloway, L. Albizu, S.C. Sealfon, and J. Gonzalez-Maeso Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists Neurosci Lett 493 2011 76 79
44. D.A. Morilak, S.J. Garlow, and R.D. Ciaranello Immunocytochemical localization and description of neurons expressing serotonin(2) receptors in the rat-brain Neuroscience 54 1993 701 717 (Pubitemid 23171330)
45. H. Ohishi, A. Neki, and N. Mizuno Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody Neurosci Res 30 1998 65 82 (Pubitemid 28119150)
46. K. Ossowska, M. Pietraszek, J. Wardas, G. Nowak, W. Zajaczkowski, and S. Wolfarth The role of glutamate receptors in antipsychotic drug action Amino Acids 19 2000 87 94
47. A. Ouagazzal, A.J. Grottick, J. Moreau, and G.A. Higgins Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains Neuropsychopharmacology 25 2001 565 575 (Pubitemid 32830961)
48. R.A. Padich, T.C. McCloskey, and J.H. Kehne 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats Psychopharmacology (Berl) 124 1996 107 116
49. S.T. Patil, L. Zhang, F. Martenyi, S.L. Lowe, K.A. Jackson, and B.V. Andreev Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial Nat Med 13 2007 1102 1107 (Pubitemid 47517511)
50. L. Pozzi, M. Baviera, G. Sacchetti, E. Calcagno, C. Balducci, and R.W. Invernizzi Attention deficit induced by blockade of N-methyl d-aspartate receptors in the prefrontal cortex is associated with enhanced glutamate release and cAMP response element binding protein phosphorylation: role of metabotropic glutamate receptors 2/3 Neuroscience 176 2011 336 348
51. B.B. Quednow, A. Schmechtig, U. Ettinger, N. Petrovsky, D.A. Collier, and F.X. Vollenweider Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study Biol Psychiatry 66 2009 614 620
52. B.B. Quednow, M. Kometer, M.A. Geyer, and F.X. Vollenweider Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers Neuropsychopharmacology 37 2012 630 640
53. L.M. Rorick-Kehn, B.G. Johnson, K.M. Knitowski, C.R. Salhoff, J.M. Witkin, and K.W. Perry In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders Psychopharmacology (Berl) 193 2007 121 136 (Pubitemid 46906627)
54. G. Sandner, and N.M. Canal Relationship between PPI and baseline startle response Cogn Neurodyn 1 2007 27 37
55. A. Satow, S. Maehara, S. Ise, H. Hikichi, M. Fukushima, and G. Suzuki Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl] -N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide] J Pharmacol Exp Ther 326 2008 577 586
56. C. Schlumberger, D. Schafer, C. Barberi, L. More, J. Nagel, and M. Pietraszek Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition Behav Pharmacol 20 2009 56 66
57. R. Schreiber, D. Lowe, A. Voerste, and J. De Vry LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidine Eur J Pharmacol 388 2000 R3 R4
58. T.A. Sipes, and M.A. Geyer Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats Neuropharmacology 33 1994 441 448 (Pubitemid 24168715)
59. T.A. Sipes, and M.A. Geyer 8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of action Psychopharmacology (Berl) 117 1995 41 48
60. T.E. Sipes, and M.A. Geyer DOI disruption of prepulse inhibition of startle in the rat is mediated by 5-HT(2A) and not by 5-HT(2C) receptors Behav Pharmacol 6 1995 839 842
61. T.E. Sipes, and M.A. Geyer DOI disrupts prepulse inhibition of startle in rats via 5-HT2A receptors in the ventral pallidum Brain Res 761 1997 97 104 (Pubitemid 27314738)
62. N.R. Swerdlow, and M.A. Geyer Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia Schizophr Bull 24 1998 285 301 (Pubitemid 28404986)
63. N.R. Swerdlow, D.L. Braff, and M.A. Geyer GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats Brain Res 532 1990 146 150 (Pubitemid 20384652)
64. N.R. Swerdlow, J. Paulsen, D.L. Braff, N. Butters, M.A. Geyer, and M.R. Swenson Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease J Neurol Neurosurg Psychiatry 58 1995 192 200
65. N.R. Swerdlow, Z.A. Martinez, F.M. Hanlon, A. Platten, M. Farid, and P. Auerbach Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists J Neurosci 20 2000 4325 4336 (Pubitemid 30365703)
66. N.R. Swerdlow, M.A. Geyer, and D.L. Braff Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges Psychopharmacology (Berl) 156 2001 194 215 (Pubitemid 32702213)
67. N.R. Swerdlow, J.M. Shoemaker, A. Platten, L. Pitcher, J. Goins, and S. Crain Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains Pharmacol Biochem Behav 75 2003 191 197 (Pubitemid 36577594)
68. G.B. Varty, and G.A. Higgins Differences between three rat strains in sensitivity to prepulse inhibition of acoustic startle response: influence of apomorphine and phencyclidine pretreatment J Psychopharmacol 8 1994 148 156 (Pubitemid 24296897)
69. G.B. Varty, and G.A. Higgins Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs Psychopharmacology (Berl) 122 1995 15 26
70. G.B. Varty, and G.A. Higgins Reversal of dizocilpine-induced disruption of prepulse inhibition of an acoustic startle response by the 5-HT2 receptor antagonist ketanserin Eur J Pharmacol 287 1995 201 205
71. A.J. Vickers The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation study BMC Med Res Methodol 1 2001 6
72. F.X. Vollenweider, P.A. Csomor, B. Knappe, M.A. Geyer, and B.B. Quednow The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval Neuropsychopharmacology 32 2007 1876 1887 (Pubitemid 47258517)
73. I.C. Weiss, L. Di Iorio, J. Feldon, and A.M. Domeney Strain differences in the isolation-induced effects on prepulse inhibition of the acoustic startle response and on locomotor activity Behav Neurosci 114 2000 364 373 (Pubitemid 30488996)
74. D.L. Willins, A.Y. Deutch, and B.L. Roth Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex Synapse 27 1997 79 82 (Pubitemid 27327604)
75. L. Wischhof, and M. Koch Pre-treatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression Psychopharmacology (Berl) 219 2012 387 400
76. L. Wischhof, K.J. Hollensteiner, and M. Koch Impulsive behaviour in rats induced by intracortical DOI infusions is antagonized by co-administration of an mGlu2/3 receptor agonist Behav Pharmacol 22 2011 805 813
77. B.K. Yee, T. Chang, S. Pietropaolo, and J. Feldon The expression of prepulse inhibition of the acoustic startle reflex as a function of three pulse stimulus intensities, three prepulse stimulus intensities, and three levels of startle responsiveness in C57BL6/J mice Behav Brain Res 163 2005 265 276 (Pubitemid 41138061)
78. J. Zhang, C. Forkstam, J.A. Engel, and L. Svensson Role of dopamine in prepulse inhibition of acoustic startle Psychopharmacology (Berl) 149 2000 181 188 (Pubitemid 30238957)